at Nasdaq.com (Fri, 12:21PM)
Acadia Pharmaceuticals (ACAD +1.3%) says it receiving funding from Fast Forward, LLC, a...
Acadia Pharmaceuticals (ACAD +1.3%) says it receiving funding from Fast Forward, LLC, a not-for-profit organization established by the National Multiple Sclerosis Society, and EMD Serono, a subsidiary of Merck KGaA (MCGAY.PK). The funding will go to support R&D directed at using AC-186, ACAD’s estrogen receptor (ER)-beta agonist, as a new approach to the treatment of multiple sclerosis.
From other sites
at Benzinga.com (Jan 12, 2015)
at CNBC.com (Dec 12, 2014)
at Nasdaq.com (Nov 17, 2014)
at CNBC.com (Nov 4, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs